BioJapan 2024 Exhibition announcement: Japan Healthcare Venture Summit 2024
HiPep exhibits at the forth coming Japan Healthcare Venture Summit, in BioJapan (October 9-11, Yokohama). Booth Number (...
Archives
The 18th Symposium on Biorelevant Chemistry
We will participate inThe 18th Symposium on Biorelevant Chemistry Sept 12-14, 2024 Tsukuba International Congress Center...
The 36th Symposium for Biomedical Analytical Science（BMAS2024）
On Aug. 28-29, at Shizuoka Convention-arts centerDiscussion topics: “Analytical chemistry that supports drug discovery a...
JASIS 2024, Announcement of joint exhibition
We are pleased to announce that HiPep Laboratories and Nippon Light Metal Co., Ltd. will co-exhibiting at the JASIS 2024...
The patent, AGP (Angiogenic peptides) is approved in Japan, China and USA.
The patent, AGP (Angiogenic peptides) is approved in Japan, China and USA.AGP was firstly invented in 2003 as an effecti...
Announcement of exhibition at Kyoto Online Tech Pavilion
We are going to participate our products on the Kyoto Online Tech Pavilion, a website organized by Kyoto City. Technolog...
2023-2024 SeasonalGreeting
We are looking for sales representative in Chinese speakers
产品 1 PepTenChip 系 统最近我 们 完成了所有 实际应 用的基 础 技 术 。 1 我 们 的多 肽库 具 备 了 捕捉分子 、 阵 列用 标记 多 肽组 达到 数千种之多 2搭 载 捕捉分子用的 优 良材料 、 无定形碳及其...
HiPep Laboratories focusing on bio
molecular recognition for healthcare in the next
generation, Looking for Exits: licensing out/collaboration
Download the materials here➡
Announcement of joint exhibition at BioJapan 2023
We are pleased to announce that Hi-Pep Laboratories, Inc. and Nippon Light Metal Company, Ltd. will jointly exhibit at B...